Use of exercise testing in the evaluation of interventional efficacy: an official ERS statement

This document reviews 1) the measurement properties of commonly used exercise tests in patients with chronic respiratory diseases and 2) published studies on their utilty and/or evaluation obtained from MEDLINE and Cochrane Library searches between 1990 and March 2015.Exercise tests are reliable and...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The European respiratory journal 2016-02, Vol.47 (2), p.429-460
Hauptverfasser: Puente-Maestu, Luis, Palange, Paolo, Casaburi, Richard, Laveneziana, Pierantonio, Maltais, François, Neder, J Alberto, O'Donnell, Denis E, Onorati, Paolo, Porszasz, Janos, Rabinovich, Roberto, Rossiter, Harry B, Singh, Sally, Troosters, Thierry, Ward, Susan
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 460
container_issue 2
container_start_page 429
container_title The European respiratory journal
container_volume 47
creator Puente-Maestu, Luis
Palange, Paolo
Casaburi, Richard
Laveneziana, Pierantonio
Maltais, François
Neder, J Alberto
O'Donnell, Denis E
Onorati, Paolo
Porszasz, Janos
Rabinovich, Roberto
Rossiter, Harry B
Singh, Sally
Troosters, Thierry
Ward, Susan
description This document reviews 1) the measurement properties of commonly used exercise tests in patients with chronic respiratory diseases and 2) published studies on their utilty and/or evaluation obtained from MEDLINE and Cochrane Library searches between 1990 and March 2015.Exercise tests are reliable and consistently responsive to rehabilitative and pharmacological interventions. Thresholds for clinically important changes in performance are available for several tests. In pulmonary arterial hypertension, the 6-min walk test (6MWT), peak oxygen uptake and ventilation/carbon dioxide output indices appear to be the variables most responsive to vasodilators. While bronchodilators do not always show clinically relevant effects in chronic obstructive pulmonary disease, high-intensity constant work-rate (endurance) tests (CWRET) are considerably more responsive than incremental exercise tests and 6MWTs. High-intensity CWRETs need to be standardised to reduce interindividual variability. Additional physiological information and responsiveness can be obtained from isotime measurements, particularly of inspiratory capacity and dyspnoea. Less evidence is available for the endurance shuttle walk test. Although the incremental shuttle walk test and 6MWT are reliable and less expensive than cardiopulmonary exercise testing, two repetitions are needed at baseline. All exercise tests are safe when recommended precautions are followed, with evidence suggesting that no test is safer than others.
doi_str_mv 10.1183/13993003.00745-2015
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1762029347</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1762029347</sourcerecordid><originalsourceid>FETCH-LOGICAL-c416t-2855fbf0c9b5238653a2d6e7b78d3c09992344e81aa6bc6acd63a9039077ce453</originalsourceid><addsrcrecordid>eNo9kE1PwzAMhiMEYmPwC5BQjlwKSd0mDTc0jQ9pEhKwc5SmLgT1YzTtxP49Kds42X792pYfQi45u-E8g1sOSgFjcMOYTNIoZjw9ItNRjUb5mEyZYhBxBWJCzrz_YoyLBPgpmcRCKslATIleeaRtSfEHO-tC3qPvXfNBXUP7T6S4MdVgetc2o8s1PXYbbMbaVBTL0lljt3fUjO1QuKAuXt-o702PdTCek5PSVB4v9nFGVg-L9_lTtHx5fJ7fLyObcNFHcZamZV4yq_I0hkykYOJCoMxlVoBlSqkYkgQzbozIrTC2EGDCd4pJaTFJYUaud3vXXfs9hB907bzFqjINtoPXXIqYxQoSGayws9qu9b7DUq87V5tuqznTI1l9IKv_yOqRbJi62h8Y8hqL_5kDSvgFrZdzcg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1762029347</pqid></control><display><type>article</type><title>Use of exercise testing in the evaluation of interventional efficacy: an official ERS statement</title><source>MEDLINE</source><source>EZB-FREE-00999 freely available EZB journals</source><creator>Puente-Maestu, Luis ; Palange, Paolo ; Casaburi, Richard ; Laveneziana, Pierantonio ; Maltais, François ; Neder, J Alberto ; O'Donnell, Denis E ; Onorati, Paolo ; Porszasz, Janos ; Rabinovich, Roberto ; Rossiter, Harry B ; Singh, Sally ; Troosters, Thierry ; Ward, Susan</creator><creatorcontrib>Puente-Maestu, Luis ; Palange, Paolo ; Casaburi, Richard ; Laveneziana, Pierantonio ; Maltais, François ; Neder, J Alberto ; O'Donnell, Denis E ; Onorati, Paolo ; Porszasz, Janos ; Rabinovich, Roberto ; Rossiter, Harry B ; Singh, Sally ; Troosters, Thierry ; Ward, Susan</creatorcontrib><description>This document reviews 1) the measurement properties of commonly used exercise tests in patients with chronic respiratory diseases and 2) published studies on their utilty and/or evaluation obtained from MEDLINE and Cochrane Library searches between 1990 and March 2015.Exercise tests are reliable and consistently responsive to rehabilitative and pharmacological interventions. Thresholds for clinically important changes in performance are available for several tests. In pulmonary arterial hypertension, the 6-min walk test (6MWT), peak oxygen uptake and ventilation/carbon dioxide output indices appear to be the variables most responsive to vasodilators. While bronchodilators do not always show clinically relevant effects in chronic obstructive pulmonary disease, high-intensity constant work-rate (endurance) tests (CWRET) are considerably more responsive than incremental exercise tests and 6MWTs. High-intensity CWRETs need to be standardised to reduce interindividual variability. Additional physiological information and responsiveness can be obtained from isotime measurements, particularly of inspiratory capacity and dyspnoea. Less evidence is available for the endurance shuttle walk test. Although the incremental shuttle walk test and 6MWT are reliable and less expensive than cardiopulmonary exercise testing, two repetitions are needed at baseline. All exercise tests are safe when recommended precautions are followed, with evidence suggesting that no test is safer than others.</description><identifier>ISSN: 0903-1936</identifier><identifier>EISSN: 1399-3003</identifier><identifier>DOI: 10.1183/13993003.00745-2015</identifier><identifier>PMID: 26797036</identifier><language>eng</language><publisher>England</publisher><subject>Advisory Committees ; Breath Tests ; Carbon Dioxide ; Dyspnea - etiology ; Dyspnea - physiopathology ; Europe ; Exercise Test - methods ; Exercise Tolerance ; Humans ; Hypertension, Pulmonary - complications ; Hypertension, Pulmonary - physiopathology ; Hypertension, Pulmonary - therapy ; Inspiratory Capacity ; Outcome Assessment (Health Care) ; Oxygen Consumption ; Pulmonary Disease, Chronic Obstructive - complications ; Pulmonary Disease, Chronic Obstructive - physiopathology ; Pulmonary Disease, Chronic Obstructive - therapy ; Pulmonary Medicine ; Pulmonary Ventilation ; Reproducibility of Results ; Respiratory Tract Diseases - complications ; Respiratory Tract Diseases - physiopathology ; Respiratory Tract Diseases - therapy ; Societies, Medical ; Walking</subject><ispartof>The European respiratory journal, 2016-02, Vol.47 (2), p.429-460</ispartof><rights>Copyright ©ERS 2016.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c416t-2855fbf0c9b5238653a2d6e7b78d3c09992344e81aa6bc6acd63a9039077ce453</citedby><cites>FETCH-LOGICAL-c416t-2855fbf0c9b5238653a2d6e7b78d3c09992344e81aa6bc6acd63a9039077ce453</cites><orcidid>0000-0002-7884-0726</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/26797036$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Puente-Maestu, Luis</creatorcontrib><creatorcontrib>Palange, Paolo</creatorcontrib><creatorcontrib>Casaburi, Richard</creatorcontrib><creatorcontrib>Laveneziana, Pierantonio</creatorcontrib><creatorcontrib>Maltais, François</creatorcontrib><creatorcontrib>Neder, J Alberto</creatorcontrib><creatorcontrib>O'Donnell, Denis E</creatorcontrib><creatorcontrib>Onorati, Paolo</creatorcontrib><creatorcontrib>Porszasz, Janos</creatorcontrib><creatorcontrib>Rabinovich, Roberto</creatorcontrib><creatorcontrib>Rossiter, Harry B</creatorcontrib><creatorcontrib>Singh, Sally</creatorcontrib><creatorcontrib>Troosters, Thierry</creatorcontrib><creatorcontrib>Ward, Susan</creatorcontrib><title>Use of exercise testing in the evaluation of interventional efficacy: an official ERS statement</title><title>The European respiratory journal</title><addtitle>Eur Respir J</addtitle><description>This document reviews 1) the measurement properties of commonly used exercise tests in patients with chronic respiratory diseases and 2) published studies on their utilty and/or evaluation obtained from MEDLINE and Cochrane Library searches between 1990 and March 2015.Exercise tests are reliable and consistently responsive to rehabilitative and pharmacological interventions. Thresholds for clinically important changes in performance are available for several tests. In pulmonary arterial hypertension, the 6-min walk test (6MWT), peak oxygen uptake and ventilation/carbon dioxide output indices appear to be the variables most responsive to vasodilators. While bronchodilators do not always show clinically relevant effects in chronic obstructive pulmonary disease, high-intensity constant work-rate (endurance) tests (CWRET) are considerably more responsive than incremental exercise tests and 6MWTs. High-intensity CWRETs need to be standardised to reduce interindividual variability. Additional physiological information and responsiveness can be obtained from isotime measurements, particularly of inspiratory capacity and dyspnoea. Less evidence is available for the endurance shuttle walk test. Although the incremental shuttle walk test and 6MWT are reliable and less expensive than cardiopulmonary exercise testing, two repetitions are needed at baseline. All exercise tests are safe when recommended precautions are followed, with evidence suggesting that no test is safer than others.</description><subject>Advisory Committees</subject><subject>Breath Tests</subject><subject>Carbon Dioxide</subject><subject>Dyspnea - etiology</subject><subject>Dyspnea - physiopathology</subject><subject>Europe</subject><subject>Exercise Test - methods</subject><subject>Exercise Tolerance</subject><subject>Humans</subject><subject>Hypertension, Pulmonary - complications</subject><subject>Hypertension, Pulmonary - physiopathology</subject><subject>Hypertension, Pulmonary - therapy</subject><subject>Inspiratory Capacity</subject><subject>Outcome Assessment (Health Care)</subject><subject>Oxygen Consumption</subject><subject>Pulmonary Disease, Chronic Obstructive - complications</subject><subject>Pulmonary Disease, Chronic Obstructive - physiopathology</subject><subject>Pulmonary Disease, Chronic Obstructive - therapy</subject><subject>Pulmonary Medicine</subject><subject>Pulmonary Ventilation</subject><subject>Reproducibility of Results</subject><subject>Respiratory Tract Diseases - complications</subject><subject>Respiratory Tract Diseases - physiopathology</subject><subject>Respiratory Tract Diseases - therapy</subject><subject>Societies, Medical</subject><subject>Walking</subject><issn>0903-1936</issn><issn>1399-3003</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNo9kE1PwzAMhiMEYmPwC5BQjlwKSd0mDTc0jQ9pEhKwc5SmLgT1YzTtxP49Kds42X792pYfQi45u-E8g1sOSgFjcMOYTNIoZjw9ItNRjUb5mEyZYhBxBWJCzrz_YoyLBPgpmcRCKslATIleeaRtSfEHO-tC3qPvXfNBXUP7T6S4MdVgetc2o8s1PXYbbMbaVBTL0lljt3fUjO1QuKAuXt-o702PdTCek5PSVB4v9nFGVg-L9_lTtHx5fJ7fLyObcNFHcZamZV4yq_I0hkykYOJCoMxlVoBlSqkYkgQzbozIrTC2EGDCd4pJaTFJYUaud3vXXfs9hB907bzFqjINtoPXXIqYxQoSGayws9qu9b7DUq87V5tuqznTI1l9IKv_yOqRbJi62h8Y8hqL_5kDSvgFrZdzcg</recordid><startdate>20160201</startdate><enddate>20160201</enddate><creator>Puente-Maestu, Luis</creator><creator>Palange, Paolo</creator><creator>Casaburi, Richard</creator><creator>Laveneziana, Pierantonio</creator><creator>Maltais, François</creator><creator>Neder, J Alberto</creator><creator>O'Donnell, Denis E</creator><creator>Onorati, Paolo</creator><creator>Porszasz, Janos</creator><creator>Rabinovich, Roberto</creator><creator>Rossiter, Harry B</creator><creator>Singh, Sally</creator><creator>Troosters, Thierry</creator><creator>Ward, Susan</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-7884-0726</orcidid></search><sort><creationdate>20160201</creationdate><title>Use of exercise testing in the evaluation of interventional efficacy: an official ERS statement</title><author>Puente-Maestu, Luis ; Palange, Paolo ; Casaburi, Richard ; Laveneziana, Pierantonio ; Maltais, François ; Neder, J Alberto ; O'Donnell, Denis E ; Onorati, Paolo ; Porszasz, Janos ; Rabinovich, Roberto ; Rossiter, Harry B ; Singh, Sally ; Troosters, Thierry ; Ward, Susan</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c416t-2855fbf0c9b5238653a2d6e7b78d3c09992344e81aa6bc6acd63a9039077ce453</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>Advisory Committees</topic><topic>Breath Tests</topic><topic>Carbon Dioxide</topic><topic>Dyspnea - etiology</topic><topic>Dyspnea - physiopathology</topic><topic>Europe</topic><topic>Exercise Test - methods</topic><topic>Exercise Tolerance</topic><topic>Humans</topic><topic>Hypertension, Pulmonary - complications</topic><topic>Hypertension, Pulmonary - physiopathology</topic><topic>Hypertension, Pulmonary - therapy</topic><topic>Inspiratory Capacity</topic><topic>Outcome Assessment (Health Care)</topic><topic>Oxygen Consumption</topic><topic>Pulmonary Disease, Chronic Obstructive - complications</topic><topic>Pulmonary Disease, Chronic Obstructive - physiopathology</topic><topic>Pulmonary Disease, Chronic Obstructive - therapy</topic><topic>Pulmonary Medicine</topic><topic>Pulmonary Ventilation</topic><topic>Reproducibility of Results</topic><topic>Respiratory Tract Diseases - complications</topic><topic>Respiratory Tract Diseases - physiopathology</topic><topic>Respiratory Tract Diseases - therapy</topic><topic>Societies, Medical</topic><topic>Walking</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Puente-Maestu, Luis</creatorcontrib><creatorcontrib>Palange, Paolo</creatorcontrib><creatorcontrib>Casaburi, Richard</creatorcontrib><creatorcontrib>Laveneziana, Pierantonio</creatorcontrib><creatorcontrib>Maltais, François</creatorcontrib><creatorcontrib>Neder, J Alberto</creatorcontrib><creatorcontrib>O'Donnell, Denis E</creatorcontrib><creatorcontrib>Onorati, Paolo</creatorcontrib><creatorcontrib>Porszasz, Janos</creatorcontrib><creatorcontrib>Rabinovich, Roberto</creatorcontrib><creatorcontrib>Rossiter, Harry B</creatorcontrib><creatorcontrib>Singh, Sally</creatorcontrib><creatorcontrib>Troosters, Thierry</creatorcontrib><creatorcontrib>Ward, Susan</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>The European respiratory journal</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Puente-Maestu, Luis</au><au>Palange, Paolo</au><au>Casaburi, Richard</au><au>Laveneziana, Pierantonio</au><au>Maltais, François</au><au>Neder, J Alberto</au><au>O'Donnell, Denis E</au><au>Onorati, Paolo</au><au>Porszasz, Janos</au><au>Rabinovich, Roberto</au><au>Rossiter, Harry B</au><au>Singh, Sally</au><au>Troosters, Thierry</au><au>Ward, Susan</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Use of exercise testing in the evaluation of interventional efficacy: an official ERS statement</atitle><jtitle>The European respiratory journal</jtitle><addtitle>Eur Respir J</addtitle><date>2016-02-01</date><risdate>2016</risdate><volume>47</volume><issue>2</issue><spage>429</spage><epage>460</epage><pages>429-460</pages><issn>0903-1936</issn><eissn>1399-3003</eissn><abstract>This document reviews 1) the measurement properties of commonly used exercise tests in patients with chronic respiratory diseases and 2) published studies on their utilty and/or evaluation obtained from MEDLINE and Cochrane Library searches between 1990 and March 2015.Exercise tests are reliable and consistently responsive to rehabilitative and pharmacological interventions. Thresholds for clinically important changes in performance are available for several tests. In pulmonary arterial hypertension, the 6-min walk test (6MWT), peak oxygen uptake and ventilation/carbon dioxide output indices appear to be the variables most responsive to vasodilators. While bronchodilators do not always show clinically relevant effects in chronic obstructive pulmonary disease, high-intensity constant work-rate (endurance) tests (CWRET) are considerably more responsive than incremental exercise tests and 6MWTs. High-intensity CWRETs need to be standardised to reduce interindividual variability. Additional physiological information and responsiveness can be obtained from isotime measurements, particularly of inspiratory capacity and dyspnoea. Less evidence is available for the endurance shuttle walk test. Although the incremental shuttle walk test and 6MWT are reliable and less expensive than cardiopulmonary exercise testing, two repetitions are needed at baseline. All exercise tests are safe when recommended precautions are followed, with evidence suggesting that no test is safer than others.</abstract><cop>England</cop><pmid>26797036</pmid><doi>10.1183/13993003.00745-2015</doi><tpages>32</tpages><orcidid>https://orcid.org/0000-0002-7884-0726</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0903-1936
ispartof The European respiratory journal, 2016-02, Vol.47 (2), p.429-460
issn 0903-1936
1399-3003
language eng
recordid cdi_proquest_miscellaneous_1762029347
source MEDLINE; EZB-FREE-00999 freely available EZB journals
subjects Advisory Committees
Breath Tests
Carbon Dioxide
Dyspnea - etiology
Dyspnea - physiopathology
Europe
Exercise Test - methods
Exercise Tolerance
Humans
Hypertension, Pulmonary - complications
Hypertension, Pulmonary - physiopathology
Hypertension, Pulmonary - therapy
Inspiratory Capacity
Outcome Assessment (Health Care)
Oxygen Consumption
Pulmonary Disease, Chronic Obstructive - complications
Pulmonary Disease, Chronic Obstructive - physiopathology
Pulmonary Disease, Chronic Obstructive - therapy
Pulmonary Medicine
Pulmonary Ventilation
Reproducibility of Results
Respiratory Tract Diseases - complications
Respiratory Tract Diseases - physiopathology
Respiratory Tract Diseases - therapy
Societies, Medical
Walking
title Use of exercise testing in the evaluation of interventional efficacy: an official ERS statement
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-29T01%3A48%3A14IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Use%20of%20exercise%20testing%20in%20the%20evaluation%20of%20interventional%20efficacy:%20an%20official%20ERS%20statement&rft.jtitle=The%20European%20respiratory%20journal&rft.au=Puente-Maestu,%20Luis&rft.date=2016-02-01&rft.volume=47&rft.issue=2&rft.spage=429&rft.epage=460&rft.pages=429-460&rft.issn=0903-1936&rft.eissn=1399-3003&rft_id=info:doi/10.1183/13993003.00745-2015&rft_dat=%3Cproquest_cross%3E1762029347%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1762029347&rft_id=info:pmid/26797036&rfr_iscdi=true